Immunopathology of vitiligo: A Review of literature

Autores

  • A. E. Silva Federal University of Mato Grosso, Sinop, Brazil.
  • L. Castoldi Universidade Federal de Mato Grosso

DOI:

https://doi.org/10.36560/722014133

Palavras-chave:

vitiligo, immunopathology, autoimunnity.

Resumo

Vitiligo is a morbidity characterized by depigmentation of body parts from the loss or reduction of melanocytes. The disease affects an average of 1% of the world population, usually individuals with mean age of 20, affecting both men and women regardless of race. Within existing therapies, there are many treatments being offered, however, improvements upon treatments vary from person to person and cure is rare to obtain. The etiology of vitiligo is still not clear, there are many hypothesis for his cause. Then, this study aimed to review literature regarding the latest immunological mechanisms involved in the onset of vitiligo. 

 

Biografia do Autor

A. E. Silva, Federal University of Mato Grosso, Sinop, Brazil.

Health Sciences Institute, Federal University of Mato Grosso, Sinop, Brazil.

nursing

L. Castoldi, Universidade Federal de Mato Grosso

INSTITUTO DE CIÊNCIAS DA SAÚDE, UNIVERSIDADE FEDERAL DE MATO GROSSO

ÃREA: IMUNOLOGIA

Referências

ANTELO, DP., FILGUEIRA, AL., CUNHA, JMT. Aspectos imunopatológicos do vitiligo. Med. Cutan. Iber. Lat. Am. 36: 125-136, 2008.a

URL: http://www.medigraphic.com/pdfs/cutanea/mc-2008/mc083d.pdf

ANTELO, DP., FILGUEIRA, AL., CUNHA, JMT. Redução dos linfócitos T-CD8+ citotóxicos observada com a terapia Puva em paciente com vitiligo. An. Bras. Dermatol. 83: 572-574, 2008.

URL: http://www.scielo.br/pdf/abd/v83n6/v83n06a13.pdf

BARROS, JA., Machado Filho, CD’AS., MARTINS, LC., PETTINATI, J., PINHAL, MAS. Vitiligo: avaliação histológica e clínica após curetagem seqüencial. An. Bras. Dermatol. 82: 327-335, 2007.

URL: http://www.scielo.br/pdf/abd/v82n4/v82n04a05.pdf

BASAK, PY., ADILOGLU, AK., CEYHAN, AM., TAS, T., AKKAYA, AB. The role of helper and regulatory T cells in the pathogenesis of vitiligo. Journal of the American Academy of Dermatology 60: 256-260, 2009.

URL:http://ac.els-cdn.com/S0190962208012358/1-s2.0-S0190962208012358-main.pdf?_tid=8e19418e-edb0-11e3-a2ff-00000aacb362&acdnat=1402083010_fe8926ab52da4d9184f5cd5c68bfa28f

BASSIOUNY, D., SHAKER, O. Role of interleukin-17 in the pathogenesis of vitiligo. Clinical and Experimental Dermatology 36: 292-297, 2010.

URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2230.2010.03972.x/pdf

BOORN, JGVD., Konijnenberg, D., Dellemijn, TAM., van der Veen, JPW., Bos, JD., Melief, CJM., Vyth-Dreese, FA., Luiten, RM. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. Journal of Investigative Dermatology 129: 2220-2232, 2009.

URL: http://www.nature.com/jid/journal/v129/n9/pdf/jid200932a.pdf

BUDEL, AR., GOMES, AMG., GONÇALVES, ACS., JORDÃO, JM., OSSOWSKI, AC., SKARE, TL. Associação entre vitiligo e doenças auto-imunes: prevalência no Serviço de Dermatologia do Hospital Universitário Evangélico de Curitiba. Arquivos Catarinenses de Medicina, Paraná 35: 66-70, 2006.

URL: http://www.acm.org.br/revista/pdf/artigos/358.pdf

CASARA, C., EIDT, L., CUNHA, V. Prevalence study of dermatoses referred to the phototherapy unit at the Dermatology Service of the Clinics Hospital of Porto Alegre, RS, Brazil. An. Bras. Dermatol. 88: 211-215, 2013.

URL: http://www.scielo.br/scielo.php?pid=S0365-05962013000200211&script=sci_arttext

DANESHPAZHOOH, M., MOSTOFIZADEH G, M., BEHJATI, J., AKHYANI, M., ROBATI, RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatology 6: 1-5, 2006.

URL: http://www.biomedcentral.com/content/pdf/1471-5945-6-3.pdf

DWIVEDI, M., LADDHA, NC., ARORA, P., MARFATIA, YS., BEGUM, R.. Decreased regulatory T-cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo. Pigment Cell Melanoma 26: 586-591, 2013.

URL: http://onlinelibrary.wiley.com/doi/10.1111/pcmr.12105/pdf

ESMAEILI, B., REZAEE, SA., LAYEGH, P., TAVAKKOL AFSHARI, J., DYE, P., GHAYOOR KARIMIANI, E., KALALINIA, F., RAFATPANAH, H. Expression of IL-17 and COX2 Gene in Peripheral Blood Leukocytes of Vitiligo Patients. Iran J. Allergy Asthma Immunol. 10: 81-89, 2011.

URL: http://ijaai.tums.ac.ir/files/journals/1/articles/333/public/333-333-1-PB.pdf

FARROKHI, S., HOJJAT-FARSANGI, M., NOOHPISHEH, MK., TAHMASBI, R., REZAEI, N. Assessment of the immune system in 55 Iranian patients with vitiligo. J. Eur. Acad. Dermatol. Venereol. 19: 706-711, 2005.

URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2005.01295.x/pdf

GEEL NV., SPEECKAERT, M., BROCHEZ, L., LAMBERT, J., SPEECKAERT, R. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases. J. Eur. Acad. Dermatol. Venereol. 28: 741-6, 2013.

URL: http://onlinelibrary.wiley.com/doi/10.1111/jdv.12169/pdf

GOPAL, KV., RAMA RAO, GR., KUMAR, YH., APPA RAO, MV., VASUDEV, PS. Vitiligo: A part of a systemic autoimmune process. Indian J. Dermatol .Venereol. Leprol. 73: 162-165, 2007. URL:http://www.ijdvl.com/article.asp?issn=0378-6323;year=2007;volume=73;issue=3;spage=162;epage=165;aulast=Gopal

HARTMANN, A., BRÖCKER, EB., BECKER, JC. Hypopigmentary skin disorders: current treatment options and future directions. Drugs 64: 89-107, 2004.

HOLLA, AP., SAHNI, P., KUMAR, R., PARSAD, D., KANWAR, A., MEHTA, SD. Acral vitiligo and lesions over joints treated with non-cultured epidermal cell suspension transplantation. Clinical and Experimental Dermatology 38: 332-337, 2013.

URL: http://onlinelibrary.wiley.com/doi/10.1111/ced.12040/pdf

KEMP, EH. Autoantibodies as Diagnostic and Predictive Markers of Vitiligo. Autoimmunity 37: 287-290, 2004.

MACHADO FILHO, CDAS., ALMEIDA, FA., PROTO, RS., LANDMAN, G. Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA. São Paulo Med. J. 123: 187-91, 2005.

URL: http://www.scielo.br/pdf/spmj/v123n4/a06v1234.pdf

MANDELCORN-MONSON, RL., SHEAR, NH., YAU, E., SAMBHARA, S., BARBER, BH., SPANER, D., DEBENEDETTE, MA. Cytotoxic T Lymphocyte Reactivity to gp100, MelanA/MART-1,and Tyrosinase, in HLA-A2-PositiveVitiligo Patients. The Journal of Investigative Dermatology 121; 550-556, 2003.

URL: http://www.nature.com/jid/journal/v121/n3/pdf/5601926a.pdf

MANGA, P., ORLOW, SJ. Engineering a new mouse model for vitiligo. The Journal of Investigative Dermatology 132: 1752-1755, 2012.

URL: http://www.nature.com/jid/journal/v132/n7/pdf/jid2012140a.pdf

MANTOVANI, S., GARBELLI, S., PALERMO, B., CAMPANELLI, R., BRAZZELLI, V., BORRONI, G., MARTINETTI, M., BENVENUTO, F., MERLINI, G., CUNA, GR., RIVOLTINI, L., GIACHINON, C. Molecular and Functional Bases of Self-Antigen Recognition in Long-Term Persistent Melanocyte-Specific CD8+ T Cells in One Vitiligo Patient. The Journal of Investigative Dermatology 12: 308-314, 2003.

URL: http://www.nature.com/jid/journal/v121/n2/pdf/5601882a.pdf

MONTES, LF., ABULAFIA, J., WILBORN, WH., HYDE, BM., MONTES, CM. Value of histopathology in vitiligo. Int. J. Dermatol. 42: 57-61, 2003.

URL: http://onlinelibrary.wiley.com/doi/10.1046/j.1365-4362.2003.01743.x/pdf

MOSENSON, JA., ZLOZA, A., KLARQUIST, J., BARFUSS, AJ., GUEVARA-PATINO, JA., LE POOLE, C. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 25: 88-98, 2012.

URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2011.00916.x/pdf

NAI, GA., MIOT, LBD., MIOT, HA., MARQUES, MEA. Imuno-histoquímica para diagnóstico precoce de vitiligo. J. Bras. Patol. Med. Lab. 44: 367-373, 2008.

URL: http://www.scielo.br/pdf/jbpml/v44n5/10.pdf

NUNES, DH., ESSER, LMH. Perfil epidemiológico dos pacientes com vitiligo e sua associação com doenças da tireoide. An. Bras. Dermatol. 86: 241-248, 2011.

URL: http://www.scielo.br/pdf/abd/v86n2/v86n2a06.pdf

ONGENAE, K., GEEL, NV., NAEYAERT, JM. Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Res. 16: 90-100, 2003.

URL: http://onlinelibrary.wiley.com/doi/10.1034/j.1600-0749.2003.00023.x/pdf

PARSAD, D., PANDHI, R., DOGRA, S., KUMAR, B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repig mentation in 352 vitiliginous patches. J. Am. Acad. Dermatol. 50: 63-67, 2004. URL:http://ac.els-cdn.com/S0190962203007862/1-s2.0-S0190962203007862-main.pdf?_tid=0cb58c9a-f0a5-11e3-a7de-00000aab0f27&acdnat=1402407922_d7e89a76577c5cb4187b8fa8285280fc

PICHLER, R., SFETSOS, K., BADICS, B., GUTENBRUNNER, S., BERG, J., AUBÖCK, J. Lymphocyte imbalance in vitiligo patients indicated by elevated CD4C/CD8C T-cell ratio. Wien Med Wochenschr 159: 337-341, 2009.

URL: http://download.springer.com/static/pdf/430/art%253A10.1007%252Fs10354-009-0699-z.pdf?auth66=1402580702_d4c25c58b8569972f9124fdbef9d9c15&ext=.pdf

SALDANHA, KDD., MACHADO FILHO, CD'AS., PASCHOAL, FM. Ação da mometasona tópica nos halos pigmentares de microenxertia em vitiligo. An. Bras. Dermatol. 87: 685-690, 2012.

URL: http://www.scielo.br/pdf/abd/v87n5/v87n5a02.pdf

SINGH, ZN., TRETIAKOVA, MS., SHEA, CR., PETRONIC-ROSIC, VM. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Modern Pathology 19: 1255-1260, 2006.

URL: http://www.nature.com/modpathol/journal/v19/n9/pdf/3800644a.pdf

SOUZA FILHO, LGC., RIVITTI, EA., MIYAUCHI, LM., SOTTO, MN., MARIA, DA., PUEJO, SST., ALVES, VAF. Estudo comparativo entre vitiligo, nevo halo e lúpus eritematoso vitiligóide por meio de métodos imunológicos, histológicos e imuno-histoquímicos. An. Bras. Dermatol. 80: 143-148, 2005.

URL: http://www.scielo.br/pdf/abd/v80n2/a04v80n02.pdf

SOUZA, APFS., CARVALHO, FT., ROCHA, KB., LAGES, MN., CALVETTI, Pü., CASTOLDI, L. Associação de eventos estressores ao surgimento ou agravamento de vitiligo e psoríase. PSICO 36: 167-174, 2005.

URL:file:///C:/Documents%20and%20Settings/Usu%C3%A1rio/Meus%20documentos/Downloads/1386-5020-2-PB.pdf

SPEECKAERT, R., GEEL, NV. Distribution patterns in generalized vitiligo. J. Eur. Acad. Dermatol. Venereol. 28: 755-762, 2014.

URL: http://onlinelibrary.wiley.com/doi/10.1111/jdv.12171/pdf

TEMBHRE, MK., SHARMA, VK., SHARMA, A., CHATTOPADHYAY, P., GUPTA, S. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo. Clinica Chimica Acta 424: 27-32, 2013.

URL:http://ac.els-cdn.com/S000989811300199X/1-s2.0-S000989811300199X-main.pdf?_tid=b04707ac-f0a6-11e3-87c2-00000aab0f02&acdnat=1402408626_a02086a7203e4f56524b423b0a25d31a

YAMAGUCHI, Y., HEARING, VJ. Melanocytes and their diseases. Cold Spring Harb Perspect Med. 4: 1-18, 2014.

URL: http://perspectivesinmedicine.cshlp.org/content/4/5/a017046.full.pdf+html

Downloads

Publicado

2014-07-29

Como Citar

Silva, A. E., & Castoldi, L. (2014). Immunopathology of vitiligo: A Review of literature. Scientific Electronic Archives, 7(2), 111–120. https://doi.org/10.36560/722014133